{
    "clinical_study": {
        "@rank": "146386", 
        "arm_group": {
            "arm_group_label": "Vitamin C and E", 
            "arm_group_type": "Experimental", 
            "description": "6 weeks of daily treatment with Vitamin C and E"
        }, 
        "brief_summary": {
            "textblock": "The endothelium is the lining of the blood vessels that helps prevent damage to the vessels.\n      The endothelium does not function as well as it should in adolescents with type 1 diabetes.\n      This causes future diabetes complications.  Adolescents with diabetes also have\n      abnormalities of the cells that repair the endothelium.  These abnormalities may be due to\n      damage caused by intermittent hyperglycemia. This studied is designed to study whether low\n      dose, combined Vitamin C and E supplementation improves endothelial function and repair in\n      adolescents with type 1 diabetes."
        }, 
        "brief_title": "Effects of Vitamin C and E on Endothelial Function in Adolescent Diabetes", 
        "completion_date": {
            "#text": "January 2015", 
            "@type": "Anticipated"
        }, 
        "condition": "Type 1 Diabetes Mellitus", 
        "condition_browse": {
            "mesh_term": [
                "Diabetes Mellitus", 
                "Diabetes Mellitus, Type 1"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          1. Children and adolescent with T1D between 8 and 15 years of age will be studied.\n\n          2. Started on insulin therapy immediately after diagnosis.\n\n          3. Fasting c-peptide levels must be less than 0.4 ng/ml.\n\n          4. Hgb A1c levels greater than 8.3%.\n\n          5. All subjects must be in good health other than having diabetes. Subjects with\n             hypothyroidism will be allowed assuming they are on stable thyroxine replacement and\n             have normal thyroid function tests.\n\n          6. Females on oral contraceptives will also be eligible to participate.\n\n        Exclusion Criteria:\n\n          1. History oral hypoglycemic agent use.\n\n          2. BMI>95th percentile\n\n          3. Hypertension\n\n          4. Elevated creatinine levels\n\n          5. Microalbuminuria."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "15 Years", 
            "minimum_age": "8 Years"
        }, 
        "enrollment": {
            "#text": "10", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "December 18, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02019186", 
            "org_study_id": "CCRI-VITCE"
        }, 
        "intervention": [
            {
                "arm_group_label": "Vitamin C and E", 
                "description": "<30 kg\t                                                     250 mg 30-60 kg\t                                                     500 mg >60 kg\t                                                     750 mg", 
                "intervention_name": "Vitamin C", 
                "intervention_type": "Dietary Supplement"
            }, 
            {
                "arm_group_label": "Vitamin C and E", 
                "description": "<30 kg 100 IU, 30-60 kg 200 IU, >60 kg 300 IU", 
                "intervention_name": "Vitamin E", 
                "intervention_type": "Dietary Supplement"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Ascorbic Acid", 
                "Vitamin E", 
                "Alpha-Tocopherol", 
                "Tocopherols", 
                "Tocotrienols", 
                "Vitamins"
            ]
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "keyword": [
            "type 1 diabetes", 
            "endothelial function", 
            "adolescents", 
            "vitamin C", 
            "vitamin E"
        ], 
        "lastchanged_date": "December 23, 2013", 
        "location": {
            "contact": {
                "email": "robert.hoffman@nationwidechildrens.org", 
                "last_name": "Robert P Hoffman, MD", 
                "phone": "614-722-4425"
            }, 
            "facility": {
                "address": {
                    "city": "Columbus", 
                    "country": "United States", 
                    "state": "Ohio", 
                    "zip": "43205"
                }, 
                "name": "Research Institute at Nationwide Children's Hospital"
            }, 
            "investigator": [
                {
                    "last_name": "Robert P Hoffman, MD", 
                    "role": "Principal Investigator"
                }, 
                {
                    "last_name": "Rachel Cazeau, MD", 
                    "role": "Sub-Investigator"
                }
            ], 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "1", 
        "official_title": "Effects of Vitamin C and E on Endothelial Function in Adolescent Diabetes", 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 4", 
        "primary_completion_date": {
            "#text": "January 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Endothelial function will be measured before and after 6 weeks of therapy with Vitamin C and  E", 
            "measure": "endothelial function", 
            "safety_issue": "No", 
            "time_frame": "6 weeks"
        }, 
        "reference": [
            {
                "PMID": "22925199", 
                "citation": "Hoffman RP, Dye AS, Bauer JA. Ascorbic acid blocks hyperglycemic impairment of endothelial function in adolescents with type 1 diabetes. Pediatr Diabetes. 2012 Dec;13(8):607-10. doi: 10.1111/j.1399-5448.2012.00882.x. Epub 2012 Aug 28."
            }, 
            {
                "PMID": "22701470", 
                "citation": "Dye AS, Huang H, Bauer JA, Hoffman RP. Hyperglycemia increases muscle blood flow and alters endothelial function in adolescents with type 1 diabetes. Exp Diabetes Res. 2012;2012:170380. doi: 10.1155/2012/170380. Epub 2012 Jun 3."
            }, 
            {
                "PMID": "12505749", 
                "citation": "Varvarovsk\u00e1 J, Racek J, Stozick\u00fd F, Soucek J, Trefil L, Pomahacov\u00e1 R. Parameters of oxidative stress in children with Type 1 diabetes mellitus and their relatives. J Diabetes Complications. 2003 Jan-Feb;17(1):7-10."
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02019186"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Nationwide Children's Hospital", 
            "investigator_full_name": "Robert Hoffman", 
            "investigator_title": "Professor", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "description": "Endothelial progenitor cells will be measured before and after 6 weeks of Vitamin C and E therapy", 
            "measure": "Endothelial progenitor cells", 
            "safety_issue": "No", 
            "time_frame": "6 weeks"
        }, 
        "source": "Nationwide Children's Hospital", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Nationwide Children's Hospital", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "December 2013", 
        "study_design": "Allocation: Non-Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "December 2013"
    }
}